PsyPost
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
Join
My Account
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

Researchers find DMT an ‘increasingly popular’ psychedelic drug

by Eric W. Dolan
November 30, 2013
Reading Time: 2 mins read
Share on TwitterShare on Facebook

Dimethyltryptamine moleculeThe illegal drug known as N,N-dimethyltryptamine (DMT) appears to be increasing in popularity, but is relatively safe, according to research published in the Journal of Psychopharmacology in November.

“The ratio of users for whom DMT was the last new drug versus those who reported lifetime DMT use was higher than ketamine, LSD and magic mushrooms, suggesting that it may be an increasingly popular substance for those seeking an alternative to traditionally available hallucinogens,” Dr. Adam R. Winstock of King’s College London and his colleagues wrote in the study.

DMT was first synthesized by the chemist Richard H. F. Manske in 1931. The drug’s powerful psychedelic properties were not scientifically documented until psychiatrist Stephen Szára studied DMT in the mid-1950s. Researchers later discovered the drug occurred naturally in the human body.

Though the scientific institutions of the West only recently discovered DMT, the drug was the key component of a sacred brew called ayahausca or yage that had a long history of use by South American tribes.

Winstock and his colleagues used the Global Drug Survey to compare DMT with ketamine, LSD and magic mushrooms. The survey included more than 22,000 respondents from around the world. About two percent, or 472 participants, reported that DMT was the last new drug they had tried.

Those who recently started using the drug were more likely to be younger, male and currently in education when compared with those who never used DMT.

For all the psychedelic substances, the most common source was a friend. A drug dealer was the second most common source.

DMT users said the drug provided “a short, intense and pleasurable experience with negligible negative effects.”

Google News Preferences Add PsyPost to your preferred sources

The vast majority smoked DMT and for most people the effects only lasted about 15 minutes. The majority of users also rated the effect of DMT as stronger than ketamine, magic mushrooms and LSD.

“Such potency of effect should prompt novice users to take significant care and advice when first using this drug since the rapid onset of an intense psychedelic effect may be unpleasant,” the researchers noted.

Few people felt an urge to use more of the drug. The researchers concluded that DMT “has a reasonable safety profile, with few users reporting significant negative effects when high or following an episode of use.” The median lethal dose of DMT in humans is estimated to be about 560 mg, which is 20 times a normal dose.

The harms associated with the drug are due to “bad trips,” or disturbing hallucinatory experiences. Some users also reported respiratory irritation.

“Like other psychedelic substances, DMT’s profound effects on consciousness may limit its appeal to the wider population and likely prevent habitual use, except in those who use it in within a religious context,” the researchers said.

The drug’s subjective effects were featured in the cult film Enter the Void. Watch below:

RELATED

ADHD drug shows promise in treating some symptoms of Alzheimer’s disease
MDMA

Antidepressants may offer an unexpected protective effect against fatal MDMA toxicity

June 9, 2026
Cannabidiol may ease Alzheimer’s-related brain inflammation and improve cognition
Alcohol

Heavy drinking impairs next-day cognitive functioning in college students

June 9, 2026
Psychedelic users tend to have greater objective knowledge about climate change, study finds
Depression

Psychedelic therapy standardized for clinical depression shows massive promise in pilot trial

June 8, 2026
Psychedelic mushroom extract may offer enhanced brain benefits over synthetic psilocybin
Psilocybin

Who is using psilocybin? First national survey reveals demographics of magic mushroom users

June 7, 2026
Some dark personality traits may help buffer against depression, new psychology research suggests
Psychedelic Drugs

Hallucinogen use is linked to a slight increase in heart valve disease risk

June 6, 2026
Political anger fuels support for violence mainly when voters feel ignored by the system
Psilocybin

Magic mushroom compound enhances the effectiveness of a common nerve pain medication

June 5, 2026
MDMA therapy: Side effects appear mild, but there are problems with the evidence
MDMA

Can MDMA cure PTSD? A new review of the evidence says it’s too early to tell

June 4, 2026
Scientists discover how coffee interacts with the gut microbiome to affect the human brain
Authoritarianism

New research challenges the idea that psychedelics reduce authoritarian attitudes

June 2, 2026

Follow PsyPost

The latest research, however you prefer to read it.

Daily newsletter

One email a day. The newest research, nothing else.

Google News

Get PsyPost stories in your Google News feed.

Add PsyPost to Google News
RSS feed

Use your favorite reader. We also syndicate to Apple News.

Copy RSS URL
Social media
Support independent science journalism

Ad-free reading, full archives, and weekly deep dives for members.

Become a member

Trending

  • How your attachment style is linked to the way you experience being alone
  • Scientists identify three distinct paths of cognitive decline in early Alzheimer’s disease
  • Intolerance of uncertainty is tied to emotion labeling in people with autistic traits
  • Magic mushroom compound enhances the effectiveness of a common nerve pain medication
  • Study finds no association between frequency of video game play and spatial abilities

Science of Money

  • Financial literacy boosts small businesses, but only with one key ingredient
  • The inequality warning sign: Scientists identify a key predictor of democratic decay
  • New study sheds light on how self-control and confidence shape your financial well-being
  • Economists pull apart the two reasons to raise the minimum wage
  • Can ChatGPT beat the S&P 500? Eight months of daily picks suggest no

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • Do not sell my personal information

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc